The New Treatment Landscape of Multiple Myeloma in the Perspective of New Front-line Therapies
The treatment of Multiple Myeloma is changing these years with the approval of new drugs and new combinations of therapies. In this MEDtalk, Claudio Cerchione, M.D., Ph.D., Dirigente Medico Ematologia, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori,” gives his perspective of the treatment now and in the future.
Get access to the article
If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.